Colin Xu, assistant professor in the Department of Psychology and Communication at University of Idaho, has co-authored a new ...
Verywell Health on MSN7d
Over 7,000 Bottles of Antidepressant Recalled Over Cancer RiskThe recall covers more than 7,000 bottles of duloxtine, sold as Cymbalta, due to the presence of nitrosamines.
GLP-1 medications, such as Ozempic, may interact with other drugs, causing very low blood sugar levels or disrupting the ...
Hosted on MSN9d
FDA recalls more than 7,000 bottles of antidepressant over a possible cancerous chemicalThe Food and Drug Administration announced a Class II recall for more than 7,000 bottles of an antidepressant due to a ...
The U.S. Food and Drug Administration is urging patients not to stop taking their prescribed medication if it falls under the ...
The U.S. Food and Drug Administration has recalled thousands of bottles of the antidepressant Duloxetine for potentially ...
The U.S. Food and Drug Administration (FDA) has issued a nationwide recall of thousands of bottles of antidepressants. These bottles were found to contain levels of a potentially cancer-causing ...
Most women use medication during pregnancy. Yet, selecting appropriate drugs and doses is challenging. In an article in The ...
Now, the FDA is assigning the second-highest risk level to the recall of Duloxetine Delayed-Release Capsules, produced by ...
The Oct. 10 recall is at least Breckenridge Pharmaceutical Inc.‘s second N-nitroso-duloxetine recall this year. The drug distributor is an American-based affiliate of Towa Pharmaceutical Europe.
The U.S. Food and Drug Administration recalled thousands of bottles of antidepressants due to the medicines containing high levels of a cancer-causing chemical. Now, the FDA is assigning the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback